Rheumnow Podcast
Dr Jack Cush reviews the news, journal reports and regulatory decisions from the past week on RheumNow.com
Latest episodes
Sep 5, 2023 • 7min
When do you consider switching vs cycling in patients with RA after first TNFi failure? Sponsored by AbbVie Medical Affairs
Rheumatologists Dr. Roy Fleischmann and Dr. Janet Pope discuss treatment options for patients with RA who have failed a TNFi. The experts consider switching to an alternate MOA vs cycling to another TNFi.
Sep 4, 2023 • 17min
Hard Decisions in RA (9.1.2023)
Dr. Jack Cush Reviews the news and journal reports from this past week on RheumNow; and introduces September campaign - "Hard Decisions in RA".
Aug 25, 2023 • 22min
Before You Know It (8.25.2023)
Dr. Jack Cush comments on the news and journal articles from the past week on RheumNow.com. This VEXAS scoring, scleroderma sine scleroderma and head scratchers from southeast Asia.
Aug 18, 2023 • 18min
Mono- and Oligo- are Different (8.18.2023)
Dr. Jack Cush reviews the news and journal reports from RheumNow.com this past week.
Aug 11, 2023 • 18min
Pizza and Rheumatoid Arthritis (8.11.2023)
Dr. Jack Cush reviews the news and journal reports from the wonderful wide world of Rheumatology.
Aug 4, 2023 • 19min
English for the Biologically-Challenged (8.4.2023)
Dr. Jack Cush reviews the news and journal articles from the past week on RheumNow.com. This week highlights Veterans, Vegetarians and Antenatal Corticosteroids.
Jul 31, 2023 • 19min
Composite Measure to Inform Management of Bio-naïve Patients with Psoriatic Arthritis Sponsored by AbbVie Medical Affairs
Listen as rheumatologists Dr. Philip Mease and Dr. Saakshi Khattri share their insights on using composite measures to manage patients with psoriatic arthritis. In this podcast, they discuss four composite measures used in trials of an IL-23 inhibitor.
Jul 28, 2023 • 21min
Pain in the Neck (7.28.2023)
This week, discussions reveal alarming misdiagnosis rates in the U.S. and their severe health implications. The episode delves into how cost-related non-adherence affects lupus treatment outcomes. The landscape of arthritis treatment is evolving with discussions on biosimilars and IL-1 inhibitors. Recent advancements in gout therapies include SGLT2 inhibitors, while complications in diagnosing calcium pyrophosphate deposition disease are explored. Treatment options for rheumatoid nodules are reviewed, highlighting the challenges faced by rheumatologists.
Jul 21, 2023 • 27min
Ask Cush Anything Returns (7.21.2023)
Dr. Jack Cush reviews the news and journal reports and this week, takes on 5 cases/questions from "Ask Cush Anything"
Jul 14, 2023 • 21min
Anti-Drug Antibodies with Biologics (7.13.2023)
Dr. Jack Cush Reviews the news and journal reports on CVA, TKA, PJP, ADA, and more!
